Smart approaches to glucose-responsive drug delivery

Journal of Drug Targeting

Volumn 23, Issue 7-8, 2015, Pages 651-655

  Webber, Matthew J ^a,b   Anderson, Daniel G ^a,b,c  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c Massachusetts Institute of Technology   (United States)

Author keywords

Artificial pancreas; diabetes; insulin; smart drug delivery

Indexed keywords

GLUCOSE; INSULIN; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL;

BIOCOMPATIBILITY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG SAFETY; GLYCEMIC CONTROL; GLYCOSYLATION; HUMAN; INSULIN TREATMENT; MICROCAPSULE; MOLECULAR RECOGNITION; PRIORITY JOURNAL; REACTION TIME; REVIEW; ANIMAL; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DRUG DESIGN; DRUG EFFECTS; GLUCOSE BLOOD LEVEL; METABOLISM; PATHOPHYSIOLOGY;

ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DRUG DELIVERY SYSTEMS; DRUG DESIGN; GLUCOSE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN;

EID: 84940412142     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.3109/1061186X.2015.1055749     Document Type: Review

References (76)

1. Patterson CC, Dahlquist GG, Gyurus E, et al. Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study. Lancet 2009;373:2027-33
2. Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001;414:782-7
3. Wild S, Roglic G, Green A, et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047-53
4. DeFronzo RA, Jacot E, Jequier E, et al. The effect of insulin on the disposal of intravenous glucose. Results from indirect calorimetry and hepatic and femoral venous catheterization. Diabetes 1981;30: 1000-7
5. Daneman D. Type 1 diabetes. Lancet 2006;367:847-58
6. Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403
7. de Veciana M, Major CA, Morgan MA, et al. Postprandial versus preprandial blood glucose monitoring in women with gestational diabetes mellitus requiring insulin therapy. N Engl J Med 1995;333: 1237-41
8. American Diabetes A. Diagnosis and classification of diabetes mellitus. Diabetes Care 2014;37:S81-90
9. DeWitt DE, Hirsch IB. Outpatient insulin therapy in type 1 and type 2 diabetes mellitus: scientific review. JAMA 2003;289:2254-64
10. Peyrot M, Barnett AH, Meneghini LF, Schumm-Draeger PM. Insulin adherence behaviours and barriers in the multinational Global Attitudes of Patients and Physicians in Insulin Therapy study. Diabet Med 2012;29:682-9
11. McCoy RG, Van Houten HK, Ziegenfuss JY, et al. Increased mortality of patients with diabetes reporting severe hypoglycemia. Diabetes Care 2012;35:1897-901
12. Muggeo M, Zoppini G, Bonora E, et al. Fasting plasma glucose variability predicts 10-year survival of type 2 diabetic patients: the Verona Diabetes Study. Diabetes Care 2000;23:45-50
13. Hirsch IB. Insulin analogues. N Engl J Med 2005;352:174-83
14. Owens DR. New horizons - alternative routes for insulin therapy. Nat Rev Drug Discov 2002;1:529-40
15. Chertok B, Webber MJ, Succi MD, Langer R. Drug delivery interfaces in the 21st century: from science fiction ideas to viable technologies. Mol Pharm 2013;10:3531-43
16. Qiu Y, Park K. Environment-sensitive hydrogels for drug delivery. Adv Drug Deliv Rev 2001;53:321-39
17. Bratlie KM, York RL, Invernale MA, et al. Materials for diabetes therapeutics. Adv Healthcare Mater 2012;1:267-84
18. Jimenez JL, Nettleton EJ, Bouchard M, et al. The protofilament structure of insulin amyloid fibrils. Proc Natl Acad Sci USA 2002; 99:9196-201
19. Weinzimer SA, Steil GM, Swan KL, et al. Fully automated closedloop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas. Diabetes Care 2008;31:934-9
20. El-Khatib FH, Jiang J, Damiano ER. Adaptive closed-loop control provides blood-glucose regulation using dual subcutaneous insulin and glucagon infusion in diabetic Swine. J Diabetes Sci Technol 2007;1:181-92
21. Russell SJ, El-Khatib FH, Sinha M, et al. Outpatient glycemic control with a bionic pancreas in type 1 diabetes. N Engl J Med 2014;371:313-25
22. Brown L, Munoz C, Siemer L, et al. Controlled release of insulin from polymer matrices. Control of diabetes in rats. Diabetes 1986; 35:692-7
23. Brown L, Siemer L, Munoz C, Langer R. Controlled release of insulin from polymer matrices. In vitro kinetics. Diabetes 1986;35: 684-91
24. Veiseh O, Tang BC, Whitehead KA, et al. Managing diabetes with nanomedicine: challenges and opportunities. Nat Rev Drug Discov 2015;14:45-57
25. Bankar SB, Bule MV, Singhal RS, Ananthanarayan L. Glucose oxidase - an overview. Biotechnol Adv 2009;27:489-501
26. Ishihara K, Kobayashi M, Ishimaru N, Shinohara I. Glucose-induced permeation control of insulin through a complex membrane consisting of immobilized glucose-oxidase and a poly(amine). Polym J 1984;16:625-31
27. Albin G, Horbett TA, Ratner BD. Glucose sensitive membranes for controlled delivery of insulin: insulin transport studies. J Control Release 1985;2:153-64
28. Ishihara K, Matsui K. Glucose-responsive insulin release from polymer capsule. J Polym Sci Part C - Polym Lett 1986;24:413-17
29. Ravaine V, Ancla C, Catargi B. Chemically controlled closed-loop insulin delivery. J Control Release 2008;132:2-11
30. Traitel T, Cohen Y, Kost J. Characterization of glucose-sensitive insulin release systems in simulated in vivo conditions. Biomaterials 2000;21:1679-87
31. Zhang K, Wu XY. Modulated insulin permeation across a glucosesensitive polymeric composite membrane. J Control Release 2002; 80:169-78
32. Podual K, Doyle FJ, Peppas NA. Glucose-sensitivity of glucose oxidase-containing cationic copolymer hydrogels having poly(ethylene glycol) grafts. J Control Release 2000;67:9-17
33. Gu Z, Dang TT, Ma M, et al. Glucose-responsive microgels integrated with enzyme nanocapsules for closed-loop insulin delivery. ACS Nano 2013;7:6758-66
34. Ito Y, Casolaro M, Kono K, Imanishi Y. An insulin-releasing system that is responsive to glucose. J Control Release 1989;10: 195-203
35. Cartier S, Horbett TA, Ratner BD. Glucose-sensitive membrane coated porous filters for control of hydraulic permeability and insulin delivery from a pressurized reservoir. J Membr Sci 1995; 106:17-24
36. Chu LY, Li Y, Zhu JH, et al. Control of pore size and permeability of a glucose-responsive gating membrane for insulin delivery. J Control Release 2004;97:43-53
37. Hassan CM, Doyle FJ, Peppas NA. Dynamic behavior of glucoseresponsive poly(methacrylic acid-g-ethylene glycol) hydrogels. Macromolecules 1997;30:6166-73
38. Kang SI, Bae YH. A sulfonamide based glucose-responsive hydrogel with covalently immobilized glucose oxidase and catalase. J Control Release 2003;86:115-21
39. Heller J, Chang AC, Rodd G, Grodsky GM. Release of Insulin from Ph-Sensitive Poly(Ortho Esters). J Control Release 1990;13: 295-302
40. Fischel-Ghodsian F, Brown L, Mathiowitz E, et al. Enzymatically controlled drug delivery. Proc Natl Acad Sci USA 1988;85:2403-6
41. Wu YH, Hu HM, Hu JM, Liu SY. Glucose-regulated insulin release from acid-disintegrable microgels covalently immobilized with glucose oxidase and catalase. Macromol Rapid Commun 2012;33: 1852-60
42. Gu Z, Aimetti AA, Wang Q, et al. Injectable nano-network for glucose-mediated insulin delivery. ACS Nano 2013;7:4194-201
43. Tai W, Mo R, Di J, et al. Bio-inspired synthetic nanovesicles for glucose-responsive release of insulin. Biomacromolecules 2014;15: 3495-502
44. Sharon N, Lis H. Lectins: cell-agglutinating and sugar-specific proteins. Science 1972;177:949-59
45. Brownlee M, Cerami A. A glucose-controlled insulin-delivery system: semisynthetic insulin bound to lectin. Science 1979;206: 1190-1
46. Pai CM, Bae YH, Mack EJ, et al. Concanavalin - a microspheres for a self-regulating insulin delivery system. J Pharm Sci 1992;81:532-6
47. Makino K, Mack EJ, Okano T, Kim SW. A microcapsule selfregulating delivery system for insulin. J Control Release 1990;12: 235-9
48. Seminoff LA, Olsen GB, Kim SW. A self-regulating insulin delivery system. 1. Characterization of a synthetic glycosylated insulin derivative. Int J Pharm 1989;54:241-9
49. Seminoff LA, Gleeson JM, Zheng J, et al. A self-regulating insulin delivery system. 2. Invivo characteristics of a synthetic glycosylated insulin. Int J Pharm 1989;54:251-7
50. Holmberg DL, Jeong SY, Kim SW, Mcrea JC. Development of a self-regulating insulin delivery system. Vet Surg 1987;16:92
51. Sung WK, Chaul MP, Makino K, et al. Self-regulated glycosylated insulin delivery. J Control Release 1990;11:193-201
52. Taylor MJ, Tanna S, Taylor PM, Adams G. The delivery of insulin from aqueous and non-aqueous reservoirs governed by a glucose sensitive gel membrane. J Drug Target 1995;3:209-16
53. Nakamae K, Miyata T, Jikihara A, Hoffman AS. Formation of poly(glucosyloxyethyl methacrylate)-concanavalin - a complex and its glucose-sensitivity. J Biomater Sci - Polym Ed 1994;6:79-90
54. Yin R, Tong Z, Yang D, Nie J. Glucose and pH dual-responsive concanavalin A based microhydrogels for insulin delivery. Int J Biol Macromol 2011;49:1137-42
55. Yin R, Tong Z, Yang D, Nie J. Glucose-responsive insulin delivery microhydrogels from methacrylated dextran/concanavalin A: preparation and in vitro release study. Carbohydr Polym 2012;89: 117-23
56. Miyata T, Jikihara A, Nakamae K, Hoffman AS. Preparation of poly(2-glucosyloxyethyl methacrylate)concanavalin A complex hydrogel and its glucose-sensitivity. Macromol Chem Phys 1996; 197:1135-46
57. Zhang R, Tang M, Bowyer A, et al. Synthesis and characterization of a D-glucose sensitive hydrogel based on CM-dextran and concanavalin A. React Funct Polym 2006;66:757-67
58. Obaidat AA, Park K. Characterization of glucose dependent gel-sol phase transition of the polymeric glucose-concanavalin A hydrogel system. Pharm Res 1996;13:989-95
59. Lee SJ, Park K. Synthesis and characterization of sol-gel phasereversible hydrogels sensitive to glucose. J Mol Recog 1996;9: 549-57
60. Obaidat AA, Park K. Characterization of protein release through glucose-sensitive hydrogel membranes. Biomaterials 1997;18: 801-6
61. Wu S, Huang X, Du X. Glucose- and pH-responsive controlled release of cargo from protein-gated carbohydrate-functionalized mesoporous silica nanocontainers. Angew Chem Int Ed Engl 2013; 52:5580-4
62. Miyata T, Jikihara A, Nakamae K, Hoffman AS. Preparation of reversibly glucose-responsive hydrogels by covalent immobilization of lectin in polymer networks having pendant glucose. J Biomater Sci - Polym Ed 2004;15:1085-98
63. Tanna S, Taylor MJ, Adams G. Insulin delivery governed by covalently modified lectin-glycogen gels sensitive to glucose. J Pharm Pharmacol 1999;51:1093-8
64. Tanna S, Sahota T, Clark J, Taylor MJ. Covalent coupling of concanavalin A to a Carbopol 934P and 941P carrier in glucosesensitive gels for delivery of insulin. J Pharm Pharmacol 2002;54: 1461-9
65. Kataoka K, Miyazaki H, Bunya M, et al. Totally synthetic polymer gels responding to external glucose concentration: their preparation and application to on-off regulation of insulin release. J Am Chem Soc 1998;120:12694-5
66. James TD, Sandanayake KRAS, Shinkai S. Saccharide sensing with molecular receptors based on boronic acid. Angew Chem Int Ed 1996;35:1910-22
67. Kataoka K, Miyazaki H, Okano T, Sakurai Y. Sensitive glucoseinduced change of the lower critical solution temperature of poly[N,N-dimethylacrylamide-Co-3-(acrylamido)phenyl-boronic acid] in physiological saline. Macromolecules 1994;27:1061-2
68. Kitano S, Koyama Y, Kataoka K, et al. A novel drug delivery system utilizing a glucose responsive polymer complex between poly(vinyl alcohol) and poly(N-vinyl-2-pyrrolidone) with a phenylboronic acid moiety. J Control Release 1992;19:162-70
69. Shiino D, Murata Y, Kataoka K, et al. Preparation and characterization of a glucose-responsive insulin-releasing polymer device. Biomaterials 1994;15:121-8
70. Matsumoto A, Ikeda S, Harada A, Kataoka K. Glucose-responsive polymer bearing a novel phenylborate derivative as a glucosesensing moiety operating at physiological pH conditions. Biomacromolecules 2003;4:1410-16
71. Yan J, Springsteen G, Deeter S, Wang BH. The relationship among pK(a),pH, and binding constants in the interactions between boronic acids and diols - it is not as simple as it appears. Tetrahedron 2004;60:11205-9
72. Shiino D, Murata Y, Kubo A, et al. Amine containing phenylboronic acid gel for glucose-responsive insulin release under physiological pH. J Control Release 1995;37:269-76
73. Langer R, Anderson DG, Gu Z, Aimetti AA. Self-regulated peptide hydrogel for insulin delivery. United States: Massachusetts Institute of Technology; 2013
74. Chou DH, Webber MJ, Tang BC, et al. Glucose-responsive insulin activity by covalent modification with aliphatic phenylboronic acid conjugates. Proc Natl Acad Sci USA 2015;112:2401-6
75. Hoeg-Jensen T, Havelund S, Nielsen PK, Markussen J. Reversible insulin self-assembly under carbohydrate control. J Am Chem Soc 2005;127:6158-9
76. Hoeg-Jensen T, Ridderberg S, Havelund S, et al. Insulins with builtin glucose sensors for glucose responsive insulin release. J Pept Sci 2005;11:339-46